This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013-2014.
Location History:
- Potomac, MD (US) (2013)
- Germantown, MD (US) (2014)
Company Filing History:
Years Active: 2013-2014
Title: Yihong Ye: Innovator in Pharmaceutical Compounds
Introduction
Yihong Ye is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific biological processes. With a total of 2 patents to his name, Ye's work is paving the way for advancements in medical treatments.
Latest Patents
Yihong Ye's latest patents include innovative compounds and methods that address critical health issues. One of his patents focuses on imidazolidinone compounds, which are designed to inhibit deubiquitination and provide methods of treatment for related disorders. This invention features pharmaceutical compositions that utilize these compounds to treat deubiquitination-related disorders in subjects. Another significant patent involves hydrazone and diacyl hydrazine compounds, which serve as inhibitors of the endoplasmic reticulum-associated protein degradation (ERAD) pathway. These compounds are also identified as potent and selective inhibitors of the p97 ATPase, offering valuable tools for studying protein degradation and related processes.
Career Highlights
Yihong Ye is currently associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this capacity has allowed him to contribute to important research and development initiatives in the pharmaceutical sector.
Collaborations
Throughout his career, Yihong Ye has collaborated with esteemed colleagues, including Adrian U Wiestner and Qiuyan Wang. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in the field.
Conclusion
Yihong Ye's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biological mechanisms and a dedication to improving health outcomes.